CID 156501355

Opnurasib

Structural Information

Molecular Formula
C29H28ClN7O
SMILES
CC1=CC2=C(C=NN2)C(=C1Cl)C3=C(N(N=C3C4=CC5=C(C=C4)N(N=C5)C)C6CC7(C6)CN(C7)C(=O)C=C)C
InChI
InChI=1S/C29H28ClN7O/c1-5-24(38)36-14-29(15-36)10-20(11-29)37-17(3)25(26-21-13-31-33-22(21)8-16(2)27(26)30)28(34-37)18-6-7-23-19(9-18)12-32-35(23)4/h5-9,12-13,20H,1,10-11,14-15H2,2-4H3,(H,31,33)
InChIKey
AZUYLZMQTIKGSC-UHFFFAOYSA-N
Compound name
1-[6-[4-(5-chloro-6-methyl-1H-indazol-4-yl)-5-methyl-3-(1-methylindazol-5-yl)pyrazol-1-yl]-2-azaspiro[3.3]heptan-2-yl]prop-2-en-1-one
Related CIDs

2D Structure

compound 2d structure
3
Annotation Hits

5
References

41860
Patents

525.2044 Da
Monoisotopic Mass

4.6
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 526.21168 207.7
[M+Na]+ 548.19362 216.0
[M+NH4]+ 543.23822 207.2
[M+K]+ 564.16756 215.3
[M-H]- 524.19712 207.3
[M+Na-2H]- 546.17907 210.0
[M]+ 525.20385 207.2
[M]- 525.20495 207.2
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe